Annual ROE
-220.59%
-28.01%-14.54%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual return on equity is -220.59%, with the most recent change of -28.01% (-14.54%) on December 31, 2023.
- During the last 3 years, RSLS annual ROE has fallen by -108.50% (-96.80%).
- RSLS annual ROE is now -177.75% below its all-time high of 283.73%, reached on December 31, 2003.
Performance
RSLS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-187.93%
-0.43%-0.23%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly return on equity is -187.93%, with the most recent change of -0.43% (-0.23%) on September 30, 2024.
- Over the past year, RSLS quarterly ROE has increased by +122.12% (+39.39%).
- RSLS quarterly ROE is now -203.55% below its all-time high of -61.91%, reached on December 31, 2006.
Performance
RSLS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RSLS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.5% | +39.4% |
| 3 y3 years | -96.8% | -95.0% |
| 5 y5 years | -46.8% | +34.7% |
RSLS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.5% | at low | -32.0% | +39.4% |
| 5 y | 5-year | -96.8% | +17.1% | -103.1% | +63.5% |
| alltime | all time | -177.8% | +68.8% | -203.6% | +95.3% |
ReShape Lifesciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -187.93%(+0.2%) |
| Jun 2024 | - | -187.50%(-1.2%) |
| Mar 2024 | - | -189.71%(-7.0%) |
| Dec 2023 | -220.59%(+14.5%) | -204.05%(-34.2%) |
| Sep 2023 | - | -310.05%(+27.3%) |
| Jun 2023 | - | -243.55%(+23.5%) |
| Mar 2023 | - | -197.20%(+19.4%) |
| Dec 2022 | -192.58%(-10.3%) | -165.14%(+7.2%) |
| Sep 2022 | - | -154.11%(+8.3%) |
| Jun 2022 | - | -142.34%(-0.1%) |
| Mar 2022 | - | -142.46%(-5.8%) |
| Dec 2021 | -214.70%(+91.5%) | -151.16%(+56.8%) |
| Sep 2021 | - | -96.39%(+4.2%) |
| Jun 2021 | - | -92.52%(-29.1%) |
| Mar 2021 | - | -130.55%(+16.4%) |
| Dec 2020 | -112.09%(-57.9%) | -112.19%(-61.0%) |
| Sep 2020 | - | -287.94%(-41.6%) |
| Jun 2020 | - | -493.35%(-4.1%) |
| Mar 2020 | - | -514.34%(+13.8%) |
| Dec 2019 | -266.12%(+77.1%) | -452.08%(+10.7%) |
| Sep 2019 | - | -408.52%(+120.8%) |
| Jun 2019 | - | -185.04%(+0.1%) |
| Mar 2019 | - | -184.82%(+13.4%) |
| Dec 2018 | -150.24%(+76.2%) | -162.92%(+38.6%) |
| Sep 2018 | - | -117.54%(-3.8%) |
| Jun 2018 | - | -122.22%(+61.7%) |
| Mar 2018 | - | -75.60%(-16.7%) |
| Dec 2017 | -85.29%(-87.9%) | -90.76%(-29.6%) |
| Sep 2017 | - | -128.88%(-42.2%) |
| Jun 2017 | - | -222.95%(-67.2%) |
| Mar 2017 | - | -679.04%(-83.2%) |
| Dec 2016 | -706.62%(+43.2%) | -4030.05%(+141.6%) |
| Sep 2016 | - | -1668.17%(+14.1%) |
| Jun 2016 | - | -1461.71%(+114.7%) |
| Mar 2016 | - | -680.67%(+43.2%) |
| Dec 2015 | -493.31% | -475.25%(+28.3%) |
| Sep 2015 | - | -370.45%(+13.5%) |
| Jun 2015 | - | -326.42%(+38.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -235.76%(+15.0%) |
| Dec 2014 | -244.84%(+26.1%) | -205.05%(+7.4%) |
| Sep 2014 | - | -190.93%(+2.6%) |
| Jun 2014 | - | -186.13%(+10.3%) |
| Mar 2014 | - | -168.70%(-6.4%) |
| Dec 2013 | -194.18%(+32.1%) | -180.29%(+1.2%) |
| Sep 2013 | - | -178.14%(+8.4%) |
| Jun 2013 | - | -164.35%(+7.3%) |
| Mar 2013 | - | -153.11%(+5.8%) |
| Dec 2012 | -147.01%(+13.3%) | -144.73%(+2.2%) |
| Sep 2012 | - | -141.61%(+8.7%) |
| Jun 2012 | - | -130.31%(+1.7%) |
| Mar 2012 | - | -128.14%(+14.6%) |
| Dec 2011 | -129.72%(+122.2%) | -111.86%(+31.1%) |
| Sep 2011 | - | -85.34%(-8.9%) |
| Jun 2011 | - | -93.66%(-15.9%) |
| Mar 2011 | - | -111.32%(-28.7%) |
| Dec 2010 | -58.39%(-89.8%) | -156.15%(-51.3%) |
| Sep 2010 | - | -320.67%(-39.8%) |
| Jun 2010 | - | -532.48%(+8.0%) |
| Mar 2010 | - | -492.90%(+43.3%) |
| Dec 2009 | -572.10%(+72.3%) | -343.91%(+0.2%) |
| Sep 2009 | - | -343.20%(+39.0%) |
| Jun 2009 | - | -246.94%(+27.2%) |
| Mar 2009 | - | -194.10%(+18.9%) |
| Dec 2008 | -332.08%(+426.2%) | -163.30%(+33.3%) |
| Sep 2008 | - | -122.54%(+6.6%) |
| Jun 2008 | - | -114.99%(+20.4%) |
| Mar 2008 | - | -95.52%(-2.6%) |
| Dec 2007 | -63.11%(+1.9%) | -98.06%(-18.6%) |
| Sep 2007 | - | -120.52%(+52.4%) |
| Jun 2007 | - | -79.09%(+12.2%) |
| Mar 2007 | - | -70.50%(+13.9%) |
| Dec 2006 | -61.91%(-89.1%) | -61.91%(-92.0%) |
| Sep 2006 | - | -773.29%(+9.7%) |
| Jun 2006 | - | -704.85%(+10.8%) |
| Mar 2006 | - | -636.41%(+12.0%) |
| Dec 2005 | -567.97%(-300.2%) | -567.97% |
| Dec 2003 | 283.73% | - |
FAQ
- What is ReShape Lifesciences annual return on equity?
- What is the all time high annual ROE for ReShape Lifesciences?
- What is ReShape Lifesciences annual ROE year-on-year change?
- What is ReShape Lifesciences quarterly return on equity?
- What is the all time high quarterly ROE for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly ROE year-on-year change?
What is ReShape Lifesciences annual return on equity?
The current annual ROE of RSLS is -220.59%
What is the all time high annual ROE for ReShape Lifesciences?
ReShape Lifesciences all-time high annual return on equity is 283.73%
What is ReShape Lifesciences annual ROE year-on-year change?
Over the past year, RSLS annual return on equity has changed by -28.01% (-14.54%)
What is ReShape Lifesciences quarterly return on equity?
The current quarterly ROE of RSLS is -187.93%
What is the all time high quarterly ROE for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly return on equity is -61.91%
What is ReShape Lifesciences quarterly ROE year-on-year change?
Over the past year, RSLS quarterly return on equity has changed by +122.12% (+39.39%)